Is Aclarion, Inc. (ACON) a Buy, Sell, or Hold?
NASDAQ : ACON
Aclarion, Inc.
$2.58 USD
-$0.06 (-2.27%)
- Volume
- 26.52K
- Average Volume
- 88.61K
- Market Capitalization
- $1.38M
- P/E Ratio
- -0.28
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $12.03
- Year Low
- $2.34
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $19.65
Company Overview
NASDAQ
Brent Ness
Medical - Healthcare Information Services
Healthcare
ACON
11
US
USD
Liquidity Metrics
0.00
19.65
19.65
19.27
0.00
Sales & Valuation
$75730
17.67
0.28
-0.19
-3.45
Profitability
-$13.61
-$7.23M
-10336.12%
-10336.12%
-54.41%
-39.00%
P/E Metrics
-0.28
0.00
0.00
Analyst Price Target & Rating
2/5
2 Analysts
%
Poll Results
About Aclarion, Inc. (NASDAQ:ACON) Stock
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, Aclarion, Inc., in December 2021, having previously been known as Nocimed, Inc. ...
Aclarion Announces Texas Spine Care Center as New CLARITY Site
2026-07-07 07:01:47
PR Audio: BROOMFIELD, Colo., July 07, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc.
Aclarion Announces Texas Spine Care Center as New CLARITY Site
2026-07-07 07:00:00
Texas Spine Care Center is a high-volume orthopedic spine practice with a philosophy of understanding the exact source of a patient's pain before recommending treatment CLARITY is a prospective, randomized clinical trial designed to demonstrate Nociscan's ability to improve surgical outcomes for chronic low back pain Nociscan® aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., July 07, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced Texas Spine Care Center as a new clinical site in its CLARITY (Chronic Low bAck pain Randomized Independent Trial studY) trial.
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
2026-06-10 07:00:00
BROOMFIELD, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented intelligence (AI) algorithms through its Nociscan® platform to help physicians identify the location of chronic low back pain and support improved treatment success rates, today announced that it will be presenting at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub on Wednesday, June 17, 2026 at 8:30 AM PT at the Bellagio Resort & Hotel.
2026-06-09 07:00:49
Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion's AI-driven platform for chronic low back pain.
2026-06-09 07:00:00
Partnership supports reimbursement strategy and U.S. commercial expansion for Aclarion's AI-driven platform for chronic low back pain. Program aims to follow successful reimbursement wins in the UK that are translating into sustained scan volume growth in step with reduced market access barriers BROOMFIELD, Colo.
Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal
2026-06-08 07:06:08
PR Audio: BROOMFIELD, Colo., June 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc.
Aclarion Rejects Echo Lake Capital's Unsolicited Acquisition Proposal
2026-06-08 07:05:00
BROOMFIELD, Colo., June 08, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc. , (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today issued the following statement in response to a recent communication issued by Echo Lake Capital and its principal, Ephraim Fields.
Aclarion Stockholders Approve All Proposals at 2026 Annual Meeting
2026-06-08 07:02:29
BROOMFIELD, Colo., June 8, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that its stockholders approved all proposals at its 2026 Annual Meeting of Stockholders held on June 4, 2026.
Frequently Asked Questions
-
What is the current Aclarion, Inc. (ACON) stock price?
-
Aclarion, Inc.(NASDAQ:ACON) stock price is $2.58 in the last trading session. During the trading session, ACON stock reached the peak price of $12.03 while $2.34 was the lowest point it dropped to. The percentage change in ACON stock occurred in the recent session was --2.27% while the dollar amount for the price change in ACON stock was -$0.06.
-
ACON's industry and sector of operation?
-
The NASDAQ listed ACON is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of ACON?
-
Jeffrey John Thramann | Executive Chairman
Brent Ness | Chief Executive Officer, President & Director
Gregory A. Gould | Chief Financial Officer
Ryan Bond | Chief Strategy Officer
| -
How many employees does ACON have?
-
Number of ACON employees currently stands at 11. ACON operates from 8181 Arista Place, Broomfield, CA 94404, US.
-
Link for ACON official website?
-
Official Website of ACON is: https://www.aclarion.com
-
How do I contact ACON?
-
ACON could be contacted at phone #650-241-1741 and can also be accessed through its website. ACON operates from 8181 Arista Place, Broomfield, CA 94404, US.
-
How many shares of ACON are traded daily?
-
The average number of ACON shares traded daily for last 3 months was 88.61K.
-
What is the market cap of ACON currently?
-
The market value of ACON currently stands at $1.38M with its latest stock price at $2.58